Errors in erasure: Links between histone lysine methylation removal and disease

Progress in Drug Research

Volumn 67, Issue , 2011, Pages 69-90

  Duncan, Elizabeth M ^a   Allis, C David ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA THALASSEMIA MENTAL RETARDATION SYNDROME X LINKED PROTEIN; CATHEPSIN L; CHROMATIN HELICASE DNA BINDING 1 PROTEIN; CHROMATIN HELICASE DNA BINDING 3 PROTEIN; CHROMATIN HELICASE DNA BINDING 4 PROTEIN; CHROMATIN HELICASE DNA BINDING 5 PROTEIN; CHROMATIN HELICASE DNA BINDING 7 PROTEIN; DNA BINDING PROTEIN; HIRA PROTEIN; HISTONE; HISTONE DEMETHYLASE; HISTONE H3; JARID1B PROTEIN; JUMONJI DOMAIN CONTAINING PROTEIN D3; LSD1 PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN JMJD2C; REGULATOR PROTEIN; RETINOBLASTOMA BINDING PROTEIN 2; TUMOR SUPPRESSOR PROTEIN; UBIQUITOUS TRANSCRIBED X CHROMOSOME TETRATRICOPEPTIDE REPEAT PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; CHAPERONE; HIRA PROTEIN, HUMAN; LYSINE; TRANSCRIPTION FACTOR;

ARTICLE; DEMETHYLATION; DISEASE ASSOCIATION; HIRA GENE; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATOR GENE; ANIMAL; METABOLISM; METHYLATION; NEOPLASM; PHYSIOLOGY; REVIEW;

ANIMALS; CATHEPSIN L; CELL CYCLE PROTEINS; HISTONE CHAPERONES; HISTONE DEMETHYLASES; HISTONES; HUMANS; LYSINE; METHYLATION; NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 79952109209     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7643-8989-5_4     Document Type: Article

References (117)

1. Van Holde KE (1989) Chromatin. Springer-Verlag, New York
2. Allis CD, Jenuwien T, Reinberg D (2006) Epigenetics. Cold Spring Harbor Laboratory Press, New York
3. Allfrey VG, Faulkner R, Mirsky AE (1964) Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 51:786-794
4. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298:1039-1043 (Pubitemid 35247314)
5. Kouzarides T (2002) Histone methylation in transcriptional control. Curr Opin Genet Dev 12:198-209 (Pubitemid 34219493)
6. Plath K, Fang J, Mlynarczyk-Evans SK, Cao R, Worringer KA, Wang H, de la Cruz CC, Otte AP, Panning B, Zhang Y (2003) Role of histone H3 lysine 27 methylation in X inactivation. Science 300:131-135 (Pubitemid 36423045)
7. Strahl BD, Ohba R, Cook RG, Allis CD (1999) Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci USA 96:14967-14972 (Pubitemid 30019748)
8. Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693-705 (Pubitemid 46273577)
9. Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J, Kauer M, Tackett AJ, Chait BT, Badenhorst P et al (2006) A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442:86-90 (Pubitemid 44064214)
10. Dillon SC, Zhang X, Trievel RC, Cheng X (2005) The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol 6:227
11. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ et al (2004) Regulation of p53 activity through lysine methylation. Nature 432:353-360 (Pubitemid 39551664)
12. Su IH, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, Chait BT, Tarakhovsky A (2003) Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol 4:124-131 (Pubitemid 36193013)
13. Schneider R, Bannister AJ, Kouzarides T (2002) Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 27:396-402 (Pubitemid 34874749)
14. Bannister AJ, Schneider R, Kouzarides T (2002) Histone methylation: dynamic or static? Cell 109:801-806
15. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:1074-1080 (Pubitemid 32758077)
16. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953 (Pubitemid 40037608)
17. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y et al (2004) Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306:279-283 (Pubitemid 39336873)
18. Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, Zhang Y (2006) Histone demethylation by a family of JmjC domain-containing proteins. Nature 439:811-816 (Pubitemid 43255695)
19. Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, Antal T, Hansen KH, Helin K (2006) The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442:307-311 (Pubitemid 44114906)
20. Klose RJ, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, Tempst P, Wong J, Zhang Y (2006) The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 442:312-316 (Pubitemid 44114907)
21. Whetstine JR, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z, Spooner E, Li E, Zhang G, Colaiacovo M et al (2006) Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 125:467-481
22. Ciccone DN, Su H, Hevi S, Gay F, Lei H, Bajko J, Xu G, Li E, Chen T (2009) KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 461:415-418
23. Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E et al (2006) Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 66:11341-11347 (Pubitemid 46009965)
24. Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, Liang J, Sun L, Yang X, Shi L et al (2009) LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138:660-672
25. Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AHFM, Günther T, Buettner R, Schule R (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437:436-439 (Pubitemid 41613508)
26. Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, Opravil S, Shiekhattar R, Bedford MT, Jenuwein T et al (2007) p53 is regulated by the lysine demethylase LSD1. Nature 449:105-108 (Pubitemid 47373772)
27. Yang ZQ, Imoto I, Fukuda Y, Pimkhaokham A, Shimada Y, Imamura M, Sugano S, Nakamura Y, Inazawa J (2000) Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines. Cancer Res 60:4735-4739
28. EhrbrechtA,Muller U,WolterM,HoischenA,Koch A, Radlwimmer B,Actor B, Mincheva A, Pietsch T, Lichter P et al (2006) Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components. J Pathol 208:554-563 (Pubitemid 43329342)
29. Italiano A, Attias R, Aurias A, Perot G, Burel-Vandenbos F, Otto J, Venissac N, Pedeutour F (2006) Molecular cytogenetic characterization of a metastatic lung sarcomatoid carcinoma: 9p23 neocentromere and 9p23-p24 amplification including JAK2 and JMJD2C. Cancer Genet Cytogenet 167:122-130 (Pubitemid 43776948)
30. Yang ZQ, Imoto I, Pimkhaokham A, Shimada Y, Sasaki K, Oka M, Inazawa J (2001) A novel amplicon at 9p23-24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB. Jpn J Cancer Res 92:423-428 (Pubitemid 32427779)
31. Hu N, Wang C, Hu Y, Yang HH, Giffen C, Tang ZZ, Han XY, Goldstein AM, Emmert-Buck MR, Buetow KH et al (2005) Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res 65:2542-2546 (Pubitemid 40490048)
32. Wissmann M, Yin N, Muller JM, Greschik H, Fodor BD, Jenuwein T, Vogler C, Schneider R, Gunther T, Buettner R et al (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 9:347-353
33. Gray SG, Iglesias AH, Lizcano F, Villanueva R, Camelo S, Jingu H, Teh BT, Koibuchi N, Chin WW, Kokkotou E et al (2005) Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J Biol Chem 280:28507-28518 (Pubitemid 41105751)
34. Iwase S, Lan F, Bayliss P, de la Torre-Ubieta L, Huarte M, Qi HH, Whetstine JR, Bonni A, Roberts TM, Shi Y (2007) The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128:1077-1088 (Pubitemid 46437259)
35. Jensen LR, Amende M, Gurok U, Moser B, Gimmel V, Tzschach A, Janecke AR, Tariverdian G, Chelly J, Fryns JP et al (2005) Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am J Hum Genet 76:227-236 (Pubitemid 40129549)
36. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A, Shi Y (2007) The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447:601-605 (Pubitemid 46868038)
37. Tzschach A, Lenzner S, Moser B, Reinhardt R, Chelly J, Fryns JP, Kleefstra T, Raynaud M, Turner G, Ropers HH et al (2006) Novel JARID1C/SMCX mutations in patients with X-linked mental retardation. Hum Mutat 27:389
38. Lee MG, Norman J, Shilatifard A, Shiekhattar R (2007) Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 128:877-887 (Pubitemid 46341414)
39. Secombe J, Eisenman RN (2007) The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection. Cell Cycle 6:1324-1328 (Pubitemid 47327965)
40. Klose RJ, Yan Q, Tothova Z, Yamane K, Erdjument-Bromage H, Tempst P, Gilliland DG, Zhang Y, Kaelin WG Jr (2007) The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128:889-900 (Pubitemid 46341416)
41. Defeo-Jones D, Huang PS, Jones RE, Haskell KM, Vuocolo GA, Hanobik MG, Huber HE, Oliff A (1991) Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352:251-254 (Pubitemid 21912329)
42. Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG Jr (2005) Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol Cell 18:623-635 (Pubitemid 40804799)
43. Lu PJ, Sundquist K, BaeckstromD, PoulsomR, Hanby A, Meier-Ewert S, Jones T, Mitchell M, Pitha-Rowe P, Freemont P et al (1999) A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem 274:15633-15645
44. Yamane K, Tateishi K, Klose RJ, Fang J, Fabrizio LA, Erdjument-Bromage H, Taylor-Papadimitriou J, Tempst P, Zhang Y (2007) PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 25:801-812 (Pubitemid 46436533)
45. Secombe J, Li L, Carlos L, Eisenman RN (2007) The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev 21:537-551 (Pubitemid 46409469)
46. Lee MG, Villa R, Trojer P, Norman J, Yan K-P, Reinberg D, Di Croce L, Shiekhattar R (2007) Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318:447-450 (Pubitemid 47614529)
47. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, Issaeva I, Canaani E, Salcini AE, Helin K (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449:731-734 (Pubitemid 47552088)
48. Schones D.E.anta F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G (2007) The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130:1083-1094 (Pubitemid 47410272)
49. Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, Iwase S, Alpatov R, Issaeva I, Canaani E et al (2007) A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449:689-694 (Pubitemid 47552096)
50. Xiang Y, Zhu Z, Han G, Lin H, Xu L, Chen CD (2007) JMJD3 is a histone H3K27 demethylase. Cell Res 17:850-857 (Pubitemid 47585113)
51. van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O'Meara S, Teague J et al (2009) Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 41:521-523
52. Gil J, Bernard D, Martinez D, Beach D (2004) Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol 6:67-72 (Pubitemid 38425732)
53. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397:164-168 (Pubitemid 29050921)
54. Reddy MA, Villeneuve LM, Wang M, Lanting L, Natarajan R (2008) Role of the lysinespecific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ Res 103:615-623
55. Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M, Gudkov AV, Stark GR (2010) Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci USA 107:46-51
56. Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, Natarajan R (2008) Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaBdependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 283:26771-26781
57. Pina B, Suau P (1987) Changes in histones H2A and H3 variant composition in differentiating and mature rat brain cortical neurons. Dev Biol 123:51-58
58. Lennox RW, Cohen LH (1988) The production of tissue-specific histone complements during development. Biochem Cell Biol 66:636-649
59. Yu L, Gorovsky MA (1997) Constitutive expression, not a particular primary sequence, is the important feature of the H3 replacement variant hv2 in Tetrahymena thermophila. Mol Cell Biol 17:6303-6310 (Pubitemid 27451174)
60. Ahmad K, Henikoff S (2002) The histone variant H3.3 marks active chromatin by replicationindependent nucleosome assembly. Mol Cell 9:1191-1200 (Pubitemid 34722299)
61. Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y (2004) Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 116:51-61 (Pubitemid 38156183)
62. Ray-Gallet D, Quivy JP, Scamps C, Martini EM, Lipinski M, Almouzni G (2002) HIRA is critical for a nucleosome assembly pathway independent of DNA synthesis. Mol Cell 9:1091-1100 (Pubitemid 34626677)
63. Lamour V, Lecluse Y, Desmaze C, Spector M, Bodescot M, Aurias A, Osley MA, Lipinski M (1995) A human homolog of the S. cerevisiae HIR1 and HIR2 transcriptional repressors cloned from the DiGeorge syndrome critical region. Hum Mol Genet 4:791-799
64. Scambler PJ (2000) The 22q11 deletion syndromes. Hum Mol Genet 9:2421-2426
65. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ et al (2001) Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101 (Pubitemid 32225843)
66. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ, Demay MB, Russell RG, Factor S et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardiofacial/DiGeorge syndrome. Cell 104:619-629 (Pubitemid 32201955)
67. Roberts C, Sutherland HF, Farmer H, Kimber W, Halford S, Carey A, Brickman JM, Wynshaw-Boris A, Scambler PJ (2002) Targeted mutagenesis of the Hira gene results in gastrulation defects and patterning abnormalities of mesoendodermal derivatives prior to early embryonic lethality. Mol Cell Biol 22:2318-2328 (Pubitemid 34224636)
68. Bonnefoy E, Orsi GA, Couble P, Loppin B (2007) The essential role of Drosophila HIRA for de novo assembly of paternal chromatin at fertilization. PLoS Genet 3:1991-2006 (Pubitemid 350072062)
69. Loppin B, Bonnefoy E, Anselme C, Laurencon A, Karr TL, Couble P (2005) The histone H3.3 chaperone HIRA is essential for chromatin assembly in the male pronucleus. Nature 437:1386-1390 (Pubitemid 41568687)
70. Hodl M, Basler K (2009) Transcription in the absence of histone H3.3. Curr Biol 19:1221-1226
71. Sakai A, Schwartz BE, Goldstein S, Ahmad K (2009) Transcriptional and developmental functions of the H3.3 histone variant in Drosophila. Curr Biol 19(21):1816-1820
72. Torres-Padilla M-E, Bannister AJ, Hurd PJ, Kouzarides T, Zernicka-Goetz M (2006) Dynamic distribution of the replacement histone variant H3.3 in the mouse oocyte and preimplantation embryos. Int J Dev Biol 50:455-461 (Pubitemid 43844794)
73. van der Heijden GW, Derijck AA, Posfai E, Giele M, Pelczar P, Ramos L, Wansink DG, van der Vlag J, Peters AH, de Boer P (2007) Chromosome-wide nucleosome replacement and H3.3 incorporation during mammalian meiotic sex chromosome inactivation. Nat Genet 39:251-258 (Pubitemid 46184358)
74. Hajkova P, Ancelin K, Waldmann T, Lacoste N, Lange UC, Cesari F, Lee C, Almouzni G, Schneider R, Surani MA (2008) Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452:877-881 (Pubitemid 351550855)
75. Konev AY, Tribus M, Park SY, Podhraski V, Lim CY, Emelyanov AV, Vershilova E, Pirrotta V, Kadonaga JT, Lusser A et al (2007) CHD1 motor protein is required for deposition of histone variant H3.3 into chromatin in vivo. Science 317:1087-1090 (Pubitemid 47330193)
76. Marfella CG, Imbalzano AN (2007) The Chd family of chromatin remodelers. Mutat Res 618:30-40 (Pubitemid 46574742)
77. Ge Q, Nilasena DS, O'Brien CA, Frank MB, Targoff IN (1995) Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest 96:1730-1737
78. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E (1995) The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum 38:1389-1399
79. Seelig HP, Renz M, Targoff IN, Ge Q, Frank MB (1996) Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. Arthritis Rheum 39:1769-1771
80. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V (1982) Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65-67 (Pubitemid 12049770)
81. Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, Bredel M, Vogel H, Mills AA (2007) CHD5 is a tumor suppressor at human 1p36. Cell 128:459-475 (Pubitemid 46198889)
82. Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM (2003) CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 22:1002-1011 (Pubitemid 36313144)
83. Mori N, Morosetti R, Mizoguchi H, Koeffler HP (2003) Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p. Br J Haematol 122:226-230 (Pubitemid 36859607)
84. Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP (1998) Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 92:3405-3409 (Pubitemid 28492351)
85. Bieche I, Champeme MH, Matifas F, Cropp CS, Callahan R, Lidereau R (1993) Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 53:1990-1994 (Pubitemid 23145715)
86. Cheung TH, Lo KW, Yim SF, Poon CS, Cheung AY, Chung TK, Wong YF (2005) Clinicopathologic significance of loss of heterozygosity on chromosome 1 in cervical cancer. Gynecol Oncol 96:510-515 (Pubitemid 40127157)
87. Kleer CG, Bryant BR, Giordano TJ, Sobel M, Merino MJ (2000) Genetic changes in chromosomes 1p and 17p in thyroid cancer progression. Endocr Pathol 11:137-143 (Pubitemid 30610123)
88. Sanlaville D, Verloes A (2007) CHARGE syndrome: an update. Eur J Hum Genet 15: 389-399 (Pubitemid 46487692)
89. Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, van der Vliet WA, Huys EH, de Jong PJ, Hamel BC et al (2004) Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 36:955-957 (Pubitemid 39167490)
90. Kallen K, Robert E, Mastroiacovo P, Castilla EE, Kallen B (1999) CHARGE Association in newborns: a registry-based study. Teratology 60:334-343
91. Bajpai R, Chen DA, Rada-Iglesias A, Zhang J, Xiong Y, Helms J, Chang CP, Zhao Y, Swigut T, Wysocka J (2010) CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 463:958-962
92. Siebert JR, Graham JM Jr, MacDonald C (1985) Pathologic features of the CHARGE association: support for involvement of the neural crest. Teratology 31:331-336 (Pubitemid 15000257)
93. Schnetz MP, Bartels CF, Shastri K, Balasubramanian D, Zentner GE, Balaji R, Zhang X, Song L, Wang Z, Laframboise T et al (2009) Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res 19:590-601
94. Roberts C, Daw SC, Halford S, Scambler PJ (1997) Cloning and developmental expression analysis of chick Hira (Chira), a candidate gene for DiGeorge syndrome. Hum Mol Genet 6:237-245 (Pubitemid 27078080)
95. Wilming LG, Snoeren CA, van Rijswijk A, Grosveld F, Meijers C (1997) The murine homologue of HIRA, a DiGeorge syndrome candidate gene, is expressed in embryonic structures affected in human CATCH22 patients. Hum Mol Genet 6:247-258 (Pubitemid 27078081)
96. Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, Law M, Guo X, Li X et al (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140:678-691
97. Higgs DR, Garrick D, Anguita E, De Gobbi M, Hughes J, Muers M, Vernimmen D, Lower K, Law M, Argentaro A et al (2005) Understanding alpha-globin gene regulation: aiming to improve the management of thalassemia. Ann N Y Acad Sci 1054:92-102 (Pubitemid 43031014)
98. Allis CD, Bowen JK, Abraham GN, Glover CV, Gorovsky MA (1980) Proteolytic processing of histone H3 in chromatin: a physiologically regulated event in Tetrahymena micronuclei. Cell 20:55-64 (Pubitemid 10117300)
99. Falk MM, Grigera PR, Bergmann IE, Zibert A, Multhaup G, Beck E (1990) Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. J Virol 64:748-756 (Pubitemid 20032691)
100. Duncan EM, Muratore-Schroeder TL, Cook RG, Garcia BA, Shabanowitz J, Hunt DF, Allis CD (2008) Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell 135:284-294
101. Santos-Rosa H, Kirmizis A, Nelson C, Bartke T, Saksouk N, Cote J, Kouzarides T (2009) Histone H3 tail clipping regulates gene expression. Nat Struct Mol Biol 16:17-22
102. Barrett AJ, Rawlings ND, Woessner JF (eds) (2003) Handbook of proteolytic enzymes. Academic Press, London
103. Troen BR, Gal S, Gottesman MM (1987) Sequence and expression of the cDNA for MEP (major excreted protein), a transformation-regulated secreted cathepsin. Biochem J 246:731-735
104. Hiwasa T, Sakiyama S (1996) Nuclear localization of procathepsin L/MEP in rastransformed mouse fibroblasts. Cancer Lett 99:87-91 (Pubitemid 26030356)
105. Goulet B, Baruch A, Moon NS, Poirier M, Sansregret LL, Erickson A, Bogyo M, Nepveu A (2004) A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor. Mol Cell 14:207-219 (Pubitemid 38515648)
106. Boudreau F, Lussier CR, Mongrain S, Darsigny M, Drouin JL, Doyon G, Suh ER, Beaulieu JF, Rivard N, Perreault N (2007) Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia. FASEB J 21:3853-3865 (Pubitemid 350237603)
107. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA (1987) Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene 2:55-59 (Pubitemid 18021071)
108. Lah TT, Kos J (1998) Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem 379:125-130 (Pubitemid 28075971)
109. Goulet B, Sansregret L, Leduy L, Bogyo M, Weber E, Chauhan SS, Nepveu A (2007) Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation. Mol Cancer Res 5:899-907 (Pubitemid 47416667)
110. Imschenetzky M, Diaz F, Montecino M, Sierra F, Puchi M(1997) Identification of a cysteine protease responsible for degradation of sperm histones during male pronucleus remodeling in sea urchins. J Cell Biochem 67:304-315 (Pubitemid 27509467)
111. Concha C, Monardes A, Even Y, Morin V, Puchi M, Imschenetzky M, Geneviere AM (2005) Inhibition of cysteine protease activity disturbs DNA replication and prevents mitosis in the early mitotic cell cycles of sea urchin embryos. J Cell Physiol 204:693-703 (Pubitemid 40934666)
112. Morin V, Sanchez A, Quiñones K, Huidobro JG, Iribarren C, Bustos P, Puchi M, Genevière AM, Imschenetzky M (2008) Cathepsin L inhibitor I blocks mitotic chromosomes decondensation during cleavage cell cycles of sea urchin embryos. J Cell Physiol 216:790-795
113. Lee KH, Lee NJ, Hyun S, Park YK, Yang EG, Lee J-K, Jeong S, Yu J (2009) Histone H3 N-terminal peptide binds directly to its own mRNA: a possible mode of feedback inhibition to control translation. Chembiochem 10:1313-1316
114. Bab I, Gavish H, Namdar-Attar M, Muhlrad A, Greenberg Z, Chen Y, Mansur N, Shteyer A, Chorev M (1999) Isolation of mitogenically active C-terminal truncated pentapeptide of osteogenic growth peptide from human plasma and culture medium of murine osteoblastic cells. J Pept Res 54:408-414 (Pubitemid 29498135)
115. Bab I, Gazit D, Chorev M, Muhlrad A, Shteyer A, Greenberg Z, Namdar M, Kahn A (1992) Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J 11:1867-1873
116. Bab I, Smith E, Gavish H, Attar-Namdar M, Chorev M, Chen YC, Muhlrad A, Birnbaum MJ, Stein G, Frenkel B (1999) Biosynthesis of osteogenic growth peptide via alternative translational initiation at AUG85 of histone H4 mRNA. J Biol Chem 274:14474-14481
117. Smith E, Meyerrose TE, Kohler T, Namdar-Attar M, Bab N, Lahat O, Noh T, Li J, Karaman MW, Hacia JG et al (2005) Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo. Nucleic Acids Res 33:1298-1308 (Pubitemid 41439923)